eGFR and ACR categories and risk of adverse outcomes | ACR categories (mg/g Cr), description and range | |||||
---|---|---|---|---|---|---|
<30 | 30–300 | >300 | ||||
Normal to mildly increased | Moderately increased | Severely increased | ||||
Normoalbuminuria | Microalbuminuria | Macroalbuminuria | ||||
A1 | A2 | A3 | Total | |||
GFR categories (ml/min/1.73 m2) | ≥90 Normal and high | G1 | 923 (70.5%) [199,875] | 48 (3.5%) [9983] | 6 (0.4%) [1119] | 977 (74.4%) [210,978] |
60–89 Mild reduction | G2 | 354 (23.6%) [67,172] | 12 (0.9%) [2582] | 1 (0.1%) [178] | 367 (24.7%) [69,933] | |
30–59.9 Moderate impairment | G3 | 10 (0.6%) [1812] | 0 | 2 (0.1%) [348] | 12 (0.8%) [2161] | |
15–29.9 Severe impairment | G4 | 1 (0.1%) [194] | 0 | 1 (0.1%) [222] | 2 (0.1%) [416] | |
<15 Kidney failure | G5 | 0 | 0 | 1 (0.1%) [165] | 1 (0.1%) [165] | |
Total | 1288 (94.9%) [269,054] | 60 (4.4%) [12,566] | 11 (0.7%) [2032] | 1359 (100%) [283,652] |